Karimah Es Sabar

CIK: 0001873796

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)3 (30.0%)

Position reduction

Option Exercises (M)3 (30.0%)

Derivative conversions

Awards (A)4 (40.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CAPR

CAPRICOR THERAPEUTICS, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (10 total)

CAPR
CAPRICOR THERAPEUTICS, INC.
Apr 2, 2026
Exercise(M)
Direct
7.5K shares at avg. $3.18$24K
CAPR
CAPRICOR THERAPEUTICS, INC.
Apr 2, 2026
Sale(S)
Direct
7.5K shares at avg. $32.00$241K
CAPR
CAPRICOR THERAPEUTICS, INC.
Apr 1, 2026
Exercise(M)
Direct
53.7K shares at avg. $4.86$261K
CAPR
CAPRICOR THERAPEUTICS, INC.
Apr 1, 2026
Sale(S)
Direct
53.7K shares at avg. $31.03$1.7M
CAPR
CAPRICOR THERAPEUTICS, INC.
Mar 31, 2026
Exercise(M)
Direct
61.3K shares at avg. $4.86$298K
CAPR
CAPRICOR THERAPEUTICS, INC.
Mar 31, 2026
Sale(S)
Direct
61.3K shares at avg. $30.17$1.8M
CAPR
CAPRICOR THERAPEUTICS, INC.
Jan 5, 2026
Award(A)
Stock Option (Right to Buy)
Direct
15.5K shares-
CAPR
CAPRICOR THERAPEUTICS, INC.
Jan 2, 2025
Award(A)
Stock Option (Right to Buy)
Direct
11.9K shares-
CAPR
CAPRICOR THERAPEUTICS, INC.
Jan 2, 2025
Award(A)
Stock Option (Right to Buy)
Direct
2.5K shares-
CAPR
CAPRICOR THERAPEUTICS, INC.
Jan 2, 2025
Award(A)
Stock Option (Right to Buy)
Direct
5.8K shares-

		Type	Shares	Price		Ownership
Apr 2, 2026	CAPR CAPRICOR THERAPEUTICS, INC.	Exercise(M)	7,529	$3.18	$23,942	Direct
Apr 2, 2026	CAPR CAPRICOR THERAPEUTICS, INC.	Sale(S)	7,529	$32.00	$240,928	Direct
Apr 1, 2026	CAPR CAPRICOR THERAPEUTICS, INC.	Exercise(M)	53,735	$4.86	$261,152	Direct
Apr 1, 2026	CAPR CAPRICOR THERAPEUTICS, INC.	Sale(S)	53,735	$31.03	$1,667,225	Direct
Mar 31, 2026	CAPR CAPRICOR THERAPEUTICS, INC.	Exercise(M)	61,265	$4.86	$297,748	Direct
Mar 31, 2026	CAPR CAPRICOR THERAPEUTICS, INC.	Sale(S)	61,265	$30.17	$1,848,243	Direct
Jan 5, 2026	CAPR CAPRICOR THERAPEUTICS, INC.	Award(A) Stock Option (Right to Buy)	15,500	-	-	Direct
Jan 2, 2025	CAPR CAPRICOR THERAPEUTICS, INC.	Award(A) Stock Option (Right to Buy)	11,940	-	-	Direct
Jan 2, 2025	CAPR CAPRICOR THERAPEUTICS, INC.	Award(A) Stock Option (Right to Buy)	2,520	-	-	Direct
Jan 2, 2025	CAPR CAPRICOR THERAPEUTICS, INC.	Award(A) Stock Option (Right to Buy)	5,750	-	-	Direct

1-10 of 10 transactions

About Sabar Karimah Es

Sabar Karimah Es (SEC CIK 0001873796) files insider reports with the SEC as Director of CAPRICOR THERAPEUTICS, INC. (CAPR).

Signal8 holds 4 ownership filings by Sabar Karimah Es, all Form 4s, filed between Jan 6, 2025 and Apr 3, 2026. Those filings report 10 transactions, from Jan 2, 2025 to Apr 2, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Sabar Karimah Es's filings is in SAN DIEGO, CA.

Recent filings by Sabar Karimah Es

Apr 2, 2026: Option exercise of CAPR shares (Form 4, code M).
Apr 2, 2026: Open-market sale of CAPR shares (Form 4, code S).
Apr 1, 2026: Option exercise of CAPR shares (Form 4, code M).
Apr 1, 2026: Open-market sale of CAPR shares (Form 4, code S).
Mar 31, 2026: Option exercise of CAPR shares (Form 4, code M).

Other insiders filing for CAPRICOR THERAPEUTICS, INC. (CAPR)

Krasney Karen, EVP, GENERAL COUNSEL
Bergmann Anthony, CHIEF FINANCIAL OFFICER
Maurer Michael T, CHIEF COMMERCIAL OFFICER
Litvack Frank, Director
Marban Linda, CHIEF EXECUTIVE OFFICER
Auwaerter Paul Gisbert, Director

How to read Form 4 transaction codes